Martin Gamble's profile photo

Martin Gamble

London

Senior Reporter at Shares Magazine

ski, surf, backgammon, world music, occasional stock musings

Featured in: Favicon sharesmagazine.co.uk

Articles

  • GSK's five-in-one meningitis vaccine recommended in the US

    1 month ago | sharesmagazine.co.uk | Martin Gamble

    Meningitis vaccine recommended in US5-in-1 vaccine should increase adoptionExtended age group for RSV vaccineGSK (GSK) announced the advisory committee of the US CDC (Centre for Disease Control and prevention) had voted to recommend its 5-in-1 meningococcal vaccine Penmenvy to help protect persons over 10-years of age against different strains of meningitidis.

  • A rare opportunity to buy high-quality antibody specialist Bioventix on the cheap

    1 month ago | sharesmagazine.co.uk | Martin Gamble

    Find out how to deal online from £1.50 in a SIPP ISA or Dealing account

  • Mitie jumps 5% on raised profit guidance and new £125 million buyback

    1 month ago | sharesmagazine.co.uk | Martin Gamble

    Raised full-year profit guidanceRecord revenue of £5.1 billionNew £125 million share buybackMitie (MTO) was one of the top mid cap gainers on Wednesday (16 April), with the shares jumping 5% to a new three-year high of 128p after the facilities transformation specialist upgraded its full-year profit guidance and announced a new £125 million share buyback.

  • De La Rue agrees £263 million private equity takeover

    1 month ago | sharesmagazine.co.uk | Martin Gamble

    Recommended 130p cash offerRival bid consideredProposal has 40% backingShares in Bank of England bank note printer De La Rue (DLAR) climbed 17% to a new three-year high of 130.7p after agreeing an all-cash takeover by US private equity group Atlas at 130p per share. This follows the announcement by De La Rue on 4 February that it was launching a formal sale process.

  • Markets price in increased odds of recession as tariff uncertainty bites

    1 month ago | sharesmagazine.co.uk | Martin Gamble

    Find out how to deal online from £1.50 in a SIPP ISA or Dealing account

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
42
Tweets
52
DMs Open
No
martin gamble
martin gamble @Chilligg
15 Feb 23

Especially when the investments are made with retail public money. Why aren’t third party safeguards in place to protect investors?

martin gamble
martin gamble @Chilligg
15 Feb 23

Doing some research on IBT International Biotechnology Trust after manager SV Health Investors gave notice. Why is the government’s British Business Bank not authorised or regulated by the PRA or FCA?

martin gamble
martin gamble @Chilligg
20 Jul 21

https://t.co/29s6ae9XSC